PEBP1 and metastatic neoplasm: Raf kinase inhibitory protein (RKIP) has been identified to be a member of a novel molecular class that has been indicated to be involved in cancer progression and the suppression of metastatic tumor spread; therefore, hypermethylation and loss of RKIP expression may be used as a marker to predict the clinical outcome of advanced gastric cancer (89).